Benzinga - Wed, 14 Apr 2021 13:09:33 -0400
Benzinga - Wed, 14 Apr 2021 12:09:23 -0400
Benzinga - Tue, 30 Mar 2021 04:04:11 -0400
Benzinga - Wed, 24 Mar 2021 08:39:35 -0400
Benzinga - Wed, 03 Mar 2021 04:17:37 -0400
Benzinga - Tue, 02 Mar 2021 05:48:59 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Cormedix Inc is a biopharmaceutical company which focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical need.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CRMDCormedix0.76%301.5M

Cormedix Company Questions & Answers

Q

How do I buy Cormedix (CRMD) stock?

A

You can purchase shares of Cormedix (NASDAQ: CRMD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cormedix's (CRMD) main competitors?

Q

What is the target price for Cormedix?

A

The latest price target for Cormedix (NASDAQ: CRMD) was reported by Needham on 2021-02-17. The analyst firm set a price target for 31.00 expecting CRMD to rise to within 12 months (a possible 290.92% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is Cormedix (CRMD) stock ?

A

The stock price for Cormedix (NASDAQ: CRMD) is $7.93 last updated Today at 8:00:02 PM.

Q

When is the next Cormedix (CRMD) dividend?

A

There are no upcoming dividends for Cormedix.

Q

When is Cormedix (NASDAQ:CRMD) reporting earnings?

A

There are no earnings for Cormedix

Q

When is the upcoming split for CRMD?

A

There is no upcoming split for Cormedix.